Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer’s Disease

Effects of AZD3480 on Cognition in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase IIb Dose-Finding Study

(2018) Lutz Frölich et al.   JOURNAL OF ALZHEIMERS DISEASE

A Meta-Analysis of the Efficacy of Donepezil, Rivastigmine, Galantamine, and Memantine in Relation to Severity of Alzheimer's Disease

(2018) Simona Gabriella Di Santo et al.   JOURNAL OF ALZHEIMERS DISEASE

Effectiveness and Safety of Memantine Treatment for Alzheimer's Disease

(2018) Zhendong Yang et al.   JOURNAL OF ALZHEIMERS DISEASE

A Randomized Study of H3 Antagonist ABT-288 in Mild-To-Moderate Alzheimer's Dementia1

(2018) George M. Haig et al.   JOURNAL OF ALZHEIMERS DISEASE

Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis

(2018) Chen-Chen Tan et al.   JOURNAL OF ALZHEIMERS DISEASE

Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer’s Disease: A Randomized Controlled Trial

(2017) Jianping Jia et al.   JOURNAL OF ALZHEIMERS DISEASE

Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study

(2017) S. Bakchine et al.   JOURNAL OF ALZHEIMERS DISEASE

ABT-126 monotherapy in mild-to-moderate Alzheimer’s dementia: randomized double-blind, placebo and active controlled adaptive trial and open-label extension

(2016) Laura M. Gault et al.   Alzheimers Research & Therapy

Efficacy and adverse effects of memantine treatment for Alzheimer’s disease from randomized controlled trials

(2015) Jue Jiang et al.   NEUROLOGICAL SCIENCES

GOOD or BAD Responder? Behavioural and Neuroanatomical Markers of Clinical Response to Donepezil in Dementia

(2014) Gabriella Bottini et al.   BEHAVIOURAL NEUROLOGY

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.

(2014) M Bond et al.   HEALTH TECHNOLOGY ASSESSMENT

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

(2013) Parminder Raina et al.   ANNALS OF INTERNAL MEDICINE

The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

(2013) George T. Grossberg et al.   CNS DRUGS

A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease

(2013) Nathan Herrmann et al.   INTERNATIONAL PSYCHOGERIATRICS

Effects of Memantine on Clinical Ratings, Fluorodeoxyglucose Positron Emission Tomography Measurements, and Cerebrospinal Fluid Assays in Patients With Moderate to Severe Alzheimer Dementia

(2013) Tao Wang et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer’s Disease

(2013) Chris G. Parsons et al.   NEUROTOXICITY RESEARCH

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial

(2012) Chris Fox et al.   PLoS One

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

(2010) Gareth Maher-Edwards et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Memantine Treatment in Patients with Mild to Moderate Alzheimers Disease Already Receiving a Cholinesterase Inhibitor: A Randomized, Double-Blind, Placebo-Controlled Trial

(2008) Anton Porsteinsson et al.   Current Alzheimer Research

Donepezil Treatment of Patients with Severe Alzheimer’s Disease in a Japanese Population: Results from a 24-Week, Double-Blind, Placebo-Controlled, Randomized Trial

(2008) Akira Homma et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment

(2008) F. S. Pereira et al.   INTERNATIONAL PSYCHOGERIATRICS

Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial

(2008) Alistair Burns et al.   LANCET NEUROLOGY